Neoplastic transformation of rodent thyroid epithelial cell lines by mutant RAS genes has been widely studied as an experimental model of oncogene-induced loss of tissue-speci®c dierentiation. However, separate evidence strongly implicates RAS mutation as an early event in human thyroid tumour development at a stage prior to loss of dierentiation. To resolve this controversy we examined the short-and long-term responses of normal human thyroid epithelial cells to mutant RAS introduced by micro-injection and retroviral transduction respectively. In both cases, expression of RAS at a level sucient to induce rapid proliferation did not lead to loss of dierentiation as shown by expression of cytokeratin 18, E-cadherin, thyroglobulin, TTF-1 and Pax-8 proteins. Indeed, RAS was able to prevent, and to reverse, the loss of thyroglobulin expression which occurs normally in TSH-de®cient culture medium. These responses were partially mimicked by activation of RAF, a major RAS eector, indicating involvement of the MAP Kinase signal pathway. The striking contrast between the eect of mutant RAS on dierentiation in primary human, compared to immortalized rodent, epithelial cultures is most likely explained by the in¯uence of additional co-operating abnormalities in the latter, and highlights the need for caution in extrapolating from cell line data. Oncogene (2000) 19, 737 ± 744.
Introduction
The specialized function of thyroid follicular cells ± synthesis of thyroid hormone ± requires the expression of a set of cell type-speci®c gene products which include thyroglobulin (Tg), thyroperoxidase (TPO), thyroid-stimulating hormone receptor (TSH-R) and the Na + /I 7 symporter (NIS). This dierentiation programme is in turn maintained by at least three thyroid-speci®c transcription factors, thyroid transcription factor-1 (TTF-1) and -2 (TTF-2) and the pairedbox factor Pax-8 (Misssero et al., 1998) .
Unlike many highly dierentiated cell types, which exit the cell cycle on induction of dierentiation, in the case of thyroid epithelial cells, proliferation and dierentiation are not mutually exclusive (Pohl et al., 1990; Roger et al., 1997) . Indeed, the major physiological regulator of thyroid growth ± thyrotropin (TSH) ± also stimulates its dierentiated functions, the two responses being mediated principally by activation of the adenylyl cyclase/cyclic AMP pathway (Vassart and Dumont, 1992) .
Nevertheless, other mitogenic signals can lead to loss of dierentiation, notably epidermal growth factor and to a lesser extent hepatocyte growth factor and serum (Roger et al., 1997) . Furthermore, a large series of studies have demonstrated loss of thyroid-speci®c gene expression in thyroid cells following introduction of a variety of transforming oncogenes , in particular the RAS gene family, which is mutated in a high proportion of human thyroid tumours (Lemoine et al., 1989) . Indeed, thyroid epithelial cells have become one of the most widely used models for studying the eects of oncogene activation on cellular dierentiation. This work, however, has been based entirely on the response of non-transformed, but immortal, rodent (rat) thyroid cell lines, notably FRTL-5 (Francis-Lang et al., 1992; Gallo et al., 1992) and WRT (Kupperman et al., 1996) , in which a mutant RAS oncogene induces full transformation including growth factor and anchorage independence and morphological change, as well as loss of thyroid dierentiation.
In contrast, both clinical (Lemoine et al., 1989; Suarez et al., 1990) and experimental evidence (Bond et al., 1994) clearly show that in naturally-occurring human thyroid tumours, mutation of RAS is an early event in tumorigenesis, occurring prior to malignant transformation and at a stage ± benign follicular adenoma ± at which most dierentiated functions are maintained (Fabbro et al., 1994) . Furthermore, when expressed in normal human thyroid epithelial cells in primary culture, mutant RAS has been found to induce proliferation with no morphological transformation and in the one, limited, study to date (Lemoine et al., 1990) no evidence for loss of dierentiation. If con®rmed, this would strongly suggest that the response of the rat cell lines was not representative of the actions of mutant RAS in human thyroid tumorigenesis.
Given the importance of resolving this uncertainty, we have now carried out a detailed analysis of the short-and long-term eects of mutant RAS on dierentiation status in human thyroid follicular cells.
human thyroid tissue (Williams et al., 1988) were stably infected with an amphotropic retroviral vector encoding mutant (Val-12) H-RAS (psi-CRIP-DOEJ) (Bond et al., 1992) . As found previously (Bond et al., 1994; Lemoine et al., 1990) , this gave rise to small numbers (*50 per dish of 5610 5 cells infected) of rapidly proliferating colonies with a typical epithelial morphology (Figure 1c ), which were readily detectable by day 10, even in non-G418 selected cultures.
Normal thyroid epithelium shows a very low proliferative rate in standard culture conditions, and exhibits a very limited proliferative lifespan (Bond et al., 1994) . After no more than three population doublings (PD) cells enter a viable but quiescent state characterized by absence of mitotic activity and cell death and an increasingly¯at morphology ( Figure 1b) . As expected, therefore no colonies were observable, either with or without G418 selection, following control (vector-only) infections. (The very low proliferative rate of the normal cultures also explains the low number of colonies obtained even with the mutant RAS vector, since retroviral vectors only target cells in cycle).
Colonies induced by mutant RAS continued to proliferate for 15 ± 25 PD after which they too enter a viable, senescent-like state (not shown). Expression of the RAS transgene is sustained throughout, as shown by RT ± PCR analysis (Bond et al., 1994) and by immuno¯uorescence (not shown). Colonies were analysed at 3 weeks post-infection, while they were still rapidly proliferating, as shown by a 24 h bromodeoxyuridine (BrdU) labelling index of 34 ± 56%.
As expected (Lemoine et al., 1990) , normal (uninfected) thyroid epithelial cells soon after plating express the cytokeratin isoform CK18 which is typical of a`simple' epithelium, as well as the intercellular adhesion molecule E-cadherin, as revealed by immuno¯uorescence using monoclonal antibodies LE61 and HECD-1 respectively (Figure 1d,g ). Expression of both proteins was sustained up to 3 weeks in culture (Figure 1e,h) . Analysis of RAS colonies at 3 weeks (Figure 1f ,i) revealed levels of immuno¯uorescence equivalent to the strongest seen in 4 day cultures of uninfected cells. Thyroid cells expressing mutant RAS retain expression of thyroid-specific proteins Immuno¯uorescence analysis of normal thyroid epithelial cells 4 days after plating showed readily detectable expression of TTF-1 and Pax-8 in the nucleus of nearly all cells (Figure 2a,d ) and of Tg in the cytoplasm of the majority of cells, although with greater cell-to-cell heterogeneity (Figure 2g ). With all three antibodies, normal human primary ®broblasts showed no immunostaining above background (not shown). After 3 weeks in culture, there was a clear reduction in the percentage of cells expressing nuclear TTF-1 ( Figure  2b , Table 1 ) and a near total loss of detectable Tg expression ( Figure 2h , Table 1 ).
In contrast, in the majority (52 ± 85%) of colonies induced by mutant RAS, even after 3 weeks in culture a high proportion of cells exhibited an intensity of immuno¯uorescence for Tg ( Figure 2i , Table 1 ) comparable to that seen in 4-day cultures of normal cells. An even more complete retention of thyroidspeci®c gene expression in RAS colonies was seen for TTF-1 (Figure 2c ) and Pax-8 ( Figure 2f) .
To exclude the possible confounding eect on immuno¯uorescence analysis resulting from the marked change in cell size and shape in the 3-week-old normal cultures (Figure 1b ), for Tg we also carried out Western immunoblot analysis of total cell extracts derived from normal uninfected monolayers or from pooled colonies obtained following infection with the mutant H-RAS vector and subsequent G418 selection. Consistent with the immunocytochemistry ®ndings, Tg protein was readily detectable in normal cells after 4 days but not after 3 weeks of culture, whereas high levels were maintained in colonies expressing mutant RAS, at 3 and even at 6 weeks after infection ( Figure 3b ). This was further supported by Northern blot analysis of total RNA, which again showed readily detectable levels in RAS colonies but not in similarly aged normal cells (Figure 3a) . A similar result was obtained for a second thyroid-speci®c gene, TPO (Figure 3a) .
Assay of cyclic AMP levels in thyroid cell extracts showed, as expected, a fall from 4 days to 3 weeks in normal cultures (12.4+0.4 and 0.37+0.02 pmol/mg protein, respectively). In contrast to Tg gene expression, however, high cAMP levels were not maintained by mutant RAS, the level in pooled RAS-induced colonies at 3 weeks being only 0.21+0.01 pmol/mg.
Retroviral transduction of a constitutively-activated RAF also induced follicular cell proliferation although the resulting colonies grew more slowly and reached a smaller average size, as previously observed (Gire et al., 1999) . Immuno¯uorescence analysis of TTF-1 and Pax-8 (Table 1) revealed essentially identical ®ndings to those seen in RAS-induced colonies. However, expression of Tg was retained in a smaller percentage of colonies (39%) and, in these, in a smaller proportion of cells (Table 1) .
Microinjection of mutant RAS protein induces proliferation in thyroid cells without loss of differentiation
One potential pitfall in the above studies arises from the fact that retrovirus vectors will only stably transduce cells which are already proliferating, which represents only a tiny percentage in normal thyroid cultures. This raises the possibility that the subpopulation which gives rise to analysable colonies may be in some way atypical of the bulk population. To circumvent this, we therefore made use of the alternative approach of direct micro-injection which although only able to generate short term responses has the advantage of being able to target cells at random.
Micro-injection of recombinant mutant (Val-12) H-RAS protein induced a striking proliferative response (Figure 4a) , the BrdU nuclear labelling index increasing with the concentration of RAS protein injected, from a basal value of *0.5% in control (IgG injected) through 7.5% with 0.5 mg/ml to 26% with the highest concentration tested (5 mg/ml). Kinetic studies (using 0.5 or 1 mg/ml RAS protein and 12 h BrdU labelling time) showed signi®cant stimulation of DNA synthesis by 24 h (Figure 4b ), reaching a maximum by 48 h and persisting for at least 72 h, at which time a stimulation of mitotic activity also became evident (mitotic index: 1.6+0.2% in RAS-injected versus 0.2+0.1% in control). A dominant interfering mutant of RAS (N17) used as an additional negative control failed to stimulate DNA synthesis at any concentration. Dierent sources of primary thyroid cells gave dierent basal BrdU labelling indices, but in all cases a similar magnitude of response to mutant RAS.
Having established the ability of micro-injected mutant RAS protein to stimulate proliferation in freshly-plated primary thyroid epithelial cells, we used this model to investigate its eect on expression of thyroid dierentiation markers. Seventy-two hours after micro-injection, when DNA synthesis was maximal, immunostaining revealed no change in expression of Pax-8 in RAS injected cells compared to controls and only a slight reduction in the percentage of cells expressing Tg and TTF-1 (Table 2) . Control cells injected with IgG alone did not dier from the untreated background monolayer.
Microinjection was also used to test the ability of mutant RAS to restimulate Tg expression in 3-week-old normal cultures in which Tg is no longer detectable. Three days after microinjection of recombinant mutant RAS protein (1 mg/ml) into such cultures, 19.5+1.7% of microinjected cells were Tg-positive by immunouorescence, compared to 51% of control IgG injected cells ( Figure 5 ).
Discussion
Our data show that expression of a mutant (Val-12) H-RAS oncogene, at a level sucient to induce rapid proliferation, does not lead to loss of the dierentiated phenotype of human thyroid epithelial cells, as shown by expression of CK18, E-cadherin, Tg, TTF-1 and Pax-8 genes. On the contrary, RAS expression appears to stabilize dierentiation in culture conditions (10% serum without TSH) in which it is progressively lost in normal cells. This is shown most clearly in the case of Tg, which after 3 weeks is no longer detectable by immuno¯uorescence in normal follicular cells, whereas in RAS-induced colonies it is present at levels comparable to that in freshly-plated normal cells. Figure 5 Re-induction of thyroglobulin expression by mutant RAS in thyrocytes after prolonged culture. After 3 weeks culture in the absence of TSH, a zone of thyrocytes (located between the dashed lines) was micro-injected with recombinant mutant (Val12) H-RAS (1 mg/ml), plus rat IgG as a marker, and analysed 3 days later by immuno¯ourescence. (a) micro-injected cells revealed by TRITC-labelled anti-rat Ig (red¯uorescence); (b) expression of Tg revealed by rabbit anti-Tg followed by FITC-labelled second antibody. Tg is readily detectable in many injected cells, but not in the uninjected zones Northern blot analysis con®rmed that this is the result of sustained Tg gene expression rather than blockade of secretion/turnover of the protein. Failure of RAS to extinguish thyroid-speci®c gene expression is not con®ned to the small sub-set of cells targetted by retroviral infection but appears to be common to all cells in the population, since similar results were observed using micro-injection. Furthermore, microinjection of normal cells which had lost Tg expression after 3 weeks in culture showed directly that mutant RAS was able to restore Tg expression.
These results dier dramatically from the large number of studies performed on rat thyroid cells lines in which mutant RAS extinguishes Tg expression (Avvedimento et al., 1988; Fusco et al., 1987) . In the case of K-RAS this is associated with, and presumably due to, loss of TTF-1 expression (Francis-Lang et al., 1992) , which is an essential transcription factor for Tg expression, whereas with H-RAS, TTF-1 is still present but appears to be inactive (Francis-Lang et al., 1992) , due possibly to de®cient phosphorylation (Velasco et al., 1998) .
Although species dierence remains a possibility, the most likely explanation for this discrepancy is the existence of unknown molecular abnormalities in the rodent cell lines which alter the response to RAS signal pathway activation. This is of course highly consistent with the observation that RAS activation produces only enhanced proliferation in the human model (Lemoine et al., 1990) as opposed to full transformation in the rat lines (Fusco et al., 1987) .
There is still controversy over which RAS signal pathways are responsible for loss of dierentiation in the rat models. In FRTL-5 cells, Cobellis et al. (1998) suggest that pathways additional to RAF/ MAPK and RAC are required, whereas in WRT cells, Miller et al. (1998) were able to reproduce the eect of RAS on Tg expression using the eector mutant S35, V12 RAS which is reported to stimulate selectively the MAP kinase (MAPK) pathway. We have tested the eect of MAPK activation using micro-injection of the S35, V12 RAS protein (data not shown) and no loss of dierentiation was observed in human thyrocytes, as would of course be expected given that the fully active Val-12 RAS failed to produce this eect in these cells.
The major mechanistic question raised by our data is why in the context of primary human thyrocytes activated RAS not only fails to switch o TTF-1 expression and/or activity but furthermore appears able to substitute for TSH in maintaining high level expression of Tg. Although TSH and RAS have been reported in WRT cells to synergize with respect to the proliferative response (Al-Alawi et al., 1995) , as far as we are aware no such data exists for dierentiation. Furthermore, our data indicate that mutant RAS cannot sustain cyclic AMP levels in human thyroid cells in culture, suggesting therefore that its maintenance of Tg expression is independent of this pathway. This is intriguingly consistent with the phenotype of well-dierentiated tumours associated with RAS mutation, which often express abundant Tg (Fabbro et al., 1994) , but unlike tumours containing TSHR or GSP mutations do not lead to hyperthyroidism. This can now be explained by the absence of any concomitant stimulation of cAMP and hence other functions such as iodide trapping which are required for hormone synthesis.
The nature of the cAMP-independent pathway remains speculative. However, TTF-1 contains concensus sites for phosphorylation by one major downstream target of RAS ± MAPK (Zannini et al., 1996) ± and we also observed Tg expression in proliferating colonies of human thyroid cells induced by constitutively activated RAF oncogene, supporting the role of the RAS?RAF?MAPKK?MAPK pathway. However, RAF was unable to fully reproduce the eect of RAS, pointing to a requirement for additional RAS eector pathways for maintenance of Tg expression, potential candidates including phosphatidyl inositol-3-kinase and RAL-GDS (Marshall, 1996) . It is interesting in this respect that insulin and IGF-1 have also been shown to stimulate Tg expression in thyroid (Pohl et al., 1990; Roger et al., 1997) , again presumably via a cAMP-independent pathway.
Clearly further work is needed to explain at the molecular level how the net eect of RAS signalling can be to stimulate Tg expression in the context of human primary cells but to suppress it in rat thyroid cells lines. The present ®ndings, however, illustrate well the critical need to use the appropriate context when investigating the eects of oncogene activation on cellular dierentiation.
Materials and methods

Primary culture and retroviral gene transfer
Thyroid follicular epithelial cells were prepared by protease digestion and mechanical disaggregation from surgical samples of histologically normal human thyroid tissue (Williams et al., 1988) . Cells were seeded and maintained as monolayers in a 2 : 1 : 1 mixture of Dulbecco's modi®ed Eagles medium, Ham's F-12 and MCDB104 (Gibco/BRL, Paisley, UK) supplemented with 10% fetal calf serum (Life Technologies, Paisley, UK).
Replication-defective amphotropic retroviral vectors, encoding the Val-12 mutant of human H-RAS (psi-CRIP-DOEJ) or vector-only control (psi-CRIP-neo) were packaged in psi-CRIP cells as previously described (Bond et al., 1992) . For RAF, a constitutively activated form (DN-RAF) lacking amino acids 3 to 333 was expressed from retroviral vector PM5neo (Laker et al., 1987) and packaged in GP+AM12 cells (Gallagher et al., 1998) .
Primary cultures were plated at *5610 5 cells per 60 mm dish and infected 2 days later with retrovirus-containing medium (containing 8 mg/ml polybrene) from near-con¯uent producer cells (Bond et al., 1992) . Three days later, cells were passaged and maintained in medium with or without G418 (400 mg/ml).
Microinjection and measurement of DNA synthesis
Microinjection was performed using an Eppendorf microinjection system (micromanipulator 5171, microinjector 5146, Carl Zeiss, Oberkochen, Germany) mounted on a Zeiss microscope equipped for epi¯uorescence studies. Recombinant RAS protein was expressed as a glutathione Stransferase fusion protein in E. coli strain BL21LysE, puri®ed by anity chromatography on glutathione-Sepharose and cleaved from glutathione S-transferase with thrombin (Gire et al., 1999) .
Cytoplasmic micro-injections were performed with recombinant proteins (0.1 ± 5 mg/ml) in 10 mM Tris-HCI pH 7.4, 114 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , co-injected with non-speci®c rat IgG (Sigma) to permit unambiguous identi®cation of injected cells. Approximately 2610 711 ml of solution was injected into each cell within a marked area of the culture dish.
Twelve to 48 h after injection, cultures were incubated with 10 mM BrdU for 12 or 24 h and cells undergoing DNA synthesis were identi®ed by immuno¯uorescence with antiBrdU antibody followed by a TRITC-labelled second antibody as described previously (Gire and Wynford-Thomas, 1998) . Micro-injected cells were identi®ed by subsequent detection of co-injected rat IgG using a FITC-labelled antirat IgG antibody. For each data point, the percentage of BrdU labelled cells was determined in triplicate populations of approximately 250 micro-injected cells each, from which the mean and standard error (s.e.) were calculated.
Immunofluorescence
Monolayers were washed with phosphate-buered saline (PBS), ®xed in methanol (10 min at 7208C) and then permeabilized with 0.1% Triton X-100 in PBS for 15 min. After blocking non-speci®c antibody binding with 10% fetal calf serum in PBS for 30 min, cells were incubated for 1 h with anity-puri®ed primary antibodies at a 1 : 500 dilution followed, after washing, by the appropriate¯uorescently-labelled second antibody, either goat anti-rabbit or antimouse IgG (Southern Biotechnology) at a 1 : 100 dilution for 1 h. When required, micro-injected cells were indenti®ed by detection of co-injected rat IgG using TRITC-or FITCcoupled anti-rat IgG antibody, and nuclei were counterstained with Hoechst 33342. Dishes were mounted with Fluoromount-G and photographed with an Olympus IMT-2 microscope ®tted with a D-plan APO 206 objective using excitation/emission ®lters for FITC and rhodamine. Negative controls were performed using`irrelevant' secondary antibody and using non-thyroid cells (human diploid ®broblasts).
Antibodies
Tg expression was assessed with a rabbit polyclonal antihuman antibody (Dako, Carpinteria CA). E-cadherin was detected using a mouse monoclonal anti-human antibody (clone HECD-1, R&D Systems, Abingdon, UK), cytokeratin 18 with mouse monoclonal LE61 (Amersham, Little Chalfont, UK) and TTF-1 and Pax-8 using rabbit polyclonal anti-dog antibodies (Van Rentgerghem et al., 1995 .
Preparation of cell extract and Western blotting
Cells were lysed for 10 min at 48C in 20 mM Tris-HCl pH 7.5, buer containing 50 mM NaCl, 40 mM sodium pyrophosphate, 10 mM b-glycerophosphate, 50 mM NaF, 5 mM MgCl 2 , 200 mM sodium orthovanadate, 10 mM EGTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 20 mg/ ml leupeptin, 20 mg/ml aprotinin and 3 mM phenylmethylsulfonyl¯uoride. Insoluble material was removed by centrifugation at 10 000 g for 5 min and the supernatant stored at 7808C. Protein concentration was measured using a Bio-Rad protein assay. Proteins (30 to 50 mg) were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) and transferred to Immobilon P membranes (Millipore). Tg expression was detected using rabbit polyclonal antibody (1 : 5000) (Dako) followed by horseradish peroxidase-conjugated anti-rabbit antibody and visualized with an enhanced chemiluminescence detection kit (Amersham International Plc, Chalfont, UK).
Measurement of intracellular cAMP
Cells were incubated for 3 h in Ham's F12 medium, and then lysed in 0.1 M HCl. The lysate was evaporated to dryness and resuspended in EDTA buer. cAMP assay (Amersham) was then performed according to the manufacturer's protocol with all determinations being carried out in triplicate.
Northern blot analysis
Total RNA was isolated from monolayer cultures using RNazol B (AMS Technologies Inc) according to the manufacturer's protocol. RNA samples (20 mg) were fractionated on a 1% agarose/glyoxal gel, blotted to Hybond N + nylon membranes (Amersham) and hybridized with a 32 Plabelled 0.98 Kb PstI fragment of PhTg1 plasmid (Brocas et al., 1982) , speci®c for human Tg or with a 3 kb EcoRI insert of human cDNA clone pTPO (Libert et al., 1987) for thyroid peroxidase. Filters were re-analysed with a probe speci®c for the`housekeeping gene' GAPDH to control for variations in loading and/or transfer.
